In Finak’s dataset, EIF3B was overexpressed in invasive breast carcinoma versus normal tissue with a fold change of 3.280; as for ductal breast carcinoma, EIF3B only increased with a fold of 1.33, which suggested a higher expression of EIF3B was accompanied by tumor progression [31]. This evidence concerns the gene EIF3B and breast ductal adenocarcinoma.